Search Results for: stem cell therapy

FDA approves Advanced Cell Technology second stem cell trial for blindness

Advanced Cell Technology (ACT) announced that the FDA has approved their second human ES cell-based clinical trial, a combined Phase I/II, for the treatment of blindness. Advanced Cell Technology As a result, soon ACT will have two active, human ES cell-based clinical trials, both using the same human ES cell-based drug. The aim of the […]

FDA approves Advanced Cell Technology second stem cell trial for blindness Read More »

The trouble with teratoma: a stem cell paradox

Teratoma

The trouble with the risk of teratoma presents a stem cell paradox. Stem cells possess two traits lacking in other cells: self-renewal and pluripotency. This duo of defining functions is key to the ability of stem cells to be used to treat patients via regenerative medicine. A paradox exists because while self-renewal and pluripotency are both

The trouble with teratoma: a stem cell paradox Read More »

Parkinson’s Disease, promising new results on iPS cells

Parkinsons-Disease-stem-cells

UPDATE: A second recent study, this one in Nature Genetics has found a novel genetic link between the immune system and Parkinson’s Disease. The authors were screening for genomic variants unique to Parkinson’s patients, finding known ones but also a novel linkage. The link was with the HLA region, known to play a key role

Parkinson’s Disease, promising new results on iPS cells Read More »

Exciting stem cell progress on Alzheimer’s Disease

Test-for-Alzheimers-Disease

UPDATE: I have added more discussion at the bottom about therapeutics and how regenerative medicine might work for Alzheimer’s Disease. Alzheimer’s Disease (AD) is the most common cause of dementia throughout the world, affecting 10s of millions of people. The cost to society is staggering and on a personal level for those of us who

Exciting stem cell progress on Alzheimer’s Disease Read More »

Weekly reads: Chinese CRISPR biotechs, cultured meat war, MSCs for Alzheimer’s

HuidaGene Therapeutics, Chinese CRISPR biotech

Chinese CRISPR research continues to grow and this includes interesting CRISPR biotech firms. Some here in the U.S. worry that American gene editing firms could be lagging behind. Especially over the past year, investors and even some scientists have voiced frustration. U.S. gene editing firms like Editas have been struggling for years. Its stock is

Weekly reads: Chinese CRISPR biotechs, cultured meat war, MSCs for Alzheimer’s Read More »

Weekly reads: woolly mice & pseudo-mammoths, eye repair good news, Mesoblast $1.5M price tag

woolly mice

Ever heard of woolly mice? I hadn’t either until recently. The story begins with de-extinction research. De-extinction can be both cool and arguably a colossal waste of research dollars. The specific effort to de-extinct woolly mammoths fits that dual classification. Woolly mice on the road back to mammoths? Let’s dig into this with some news:

Weekly reads: woolly mice & pseudo-mammoths, eye repair good news, Mesoblast $1.5M price tag Read More »